Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Our goal is to create novel products to meet critical patient needs, including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
View Top Employees from APRINOIA Therapeutics| Website | http://www.aprinoia.com/ |
| Employees | 32 (28 on RocketReach) |
| Founded | 2015 |
| Phone | +886 2 7707 0608 |
| Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology Research, Health Care, Health Diagnostics, Therapeutics |
Looking for a particular APRINOIA Therapeutics employee's phone or email?
APRINOIA Therapeutics Questions
Mark Shearman is the CEO of APRINOIA Therapeutics.
28 people are employed at APRINOIA Therapeutics.
APRINOIA Therapeutics is based in Chūō Ku, Tokyo.
Top APRINOIA Therapeutics Employees
-
32
-
ViewSanjay Sehgal
Senior Vice President and Global Head, Regulatory Affairs at APRINOIA Therapeutics
Cincinnati, Ohio, United States35+ -
55+
-
33
-
42
-
1
Related Companies
